Group items tagged

Chronic renal failure, or renal overload, is associated with a variety of morbidity and mortality and is a major challenge in the clinical treatment of patients with chronic renal failure. This disease has no cure and can be managed with specific medications in an appropriate course of therapy. However, in patients for whom other therapies have been ineffective or who are experiencing life-threatening side effects, continuous renal substitute therapy (CRS) is the only feasible treatment. Continuous Renal Replacement Therapy (CRRT) is a type of blood purification therapy used in the treatment of patients with acute kidney injury. The therapy is commonly used to provide renal support for critically ill patients with acute kidney injury, particularly patients who are hemodynamically unstable. Emergence of COVID-19 has led to increasing adoption of CRRT as patients with Covid-19 are experiencing multiple organ failure, including acute kidney injury. Moreover, regulatory bodies are also focused on approval and launch of new CRRT devices. For instance, in April 2020, The U.S. Food and Drug Administration granted marketing authorization for a new device indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients weighing between 2.5 and 10 kilograms (or 5.5 to 22 pounds). Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/demand-for-continuous-renal-replacement.html

Two most common anesthesia techniques used in the United States are intravenous and inhalation. Intravenous anesthetics or commonly known as IVAs are delivered to the lungs by means of the infusion pump, whereas inhalation anesthesia or commonly called inhalation anesthetics are inhaled directly into the nose. The inhalation method is less popular than the intravenous method mainly because of the difficulty in determining the exact drug concentration needed for effective anesthesia. Several studies and clinical trials have focused on determining the efficacy of both types of anesthesia techniques. For instance, in November 2020, a new clinical trial, The Volatile vs Total intravenous Anesthesia for major non-cardiac surgery (VITAL) trial was launched to compare two types of anesthetic to determine how soon after surgery they allow patients to return home. The trail will compare two methods of delivering anesthesia to a patient: inhalation and intravenous. The main functions of inhalation anesthesia are to relieve chest pain, provide relief to the airways in asthma and reduce the amount of sepsis (severe respiratory distress) in critically ill patients. The mechanism of action is quite similar to that of different drugs in the field of medication wherein it effects the different tissues in the body to produce a desired effect. It affects the muscles, ligaments and tissues in the airways by blocking the airway. Inhalation anesthetics are also referred to as antidepressants because it affects the brain chemical systems such as those responsible for depression and anxiety. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/clinical-trial-focuses-on-determining.html

Hybrid seeds are developed by cross-breeding plants (two or more plants) of different species. Cross-pollinated will develop a seed that carries one or more desired traits. These seeds are widely used in farming (commercial) to increase yields and to develop climate and disease resistant plants. Moreover, these seeds are widely used in farming and gardening of vegetables and flowers such as sweet corn tomatoes, and roses. Hybrids are chosen to improve the characteristics of the resulting plants such as better fruit quality, better uniformity, heat and cold tolerance, early maturity, increased yield, etc. Increasing demand for vegetables and fruits from emerging economies is expected to increase the demand for hybrid seeds. Hybrid seeds are the major contributors to the rise in agricultural output since the 20th century. Several breeding companies are focused on developing the resultant crops resistant to diseases through extensive research and development activities. However, the development of such seeds may be hindered under adverse climatic conditions. In 2018, a German company launched a hybrid rice seed with robust tolerance to Brown Plant Hopper pests and Bacterial Leaf Blight. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/hybrid-seeds-increase-yields-and.html

On Independence day 2020, The government of India has launched the National Digital Health Mission to digitize the health records of citizens/patients. With this digitization, the patient will now no longer be worried to take with him/her the health records while visiting the doctor for their health issues as everything would be available online, anytime and anywhere.

The human microbiome is comprised of archaea, eukaryotes, bacteria, and viruses that reside within anatomical sites of the human body including skin, placenta, uterus, mammary glands, lung, saliva, oral mucus, etc. There have been various attempts at understanding the mechanism of this microbiome. The U.S. National Institutes of Health (NIH) launched 'The Human Microbiome Project' to enhance the understanding of microbial flora that is involved in human health and disease. The goals of the project were to reveal the diversity of the microbial community in healthy people, to assess the impact of the environment on the microbiomes of individuals, and to identify new applications for these microbes. The microorganisms in human bodies are an important part of a balanced natural system. This project is a collection of over 100 human microbiomes that was obtained from healthy individuals of the U.S. This reference panel was then compared with the microbiomes from the same individuals' stool samples. Read More @ https://coherentmarketinsights-cmi.blogspot.com/2020/11/human-microbiome-project-is-gaining.html

The emergence of COVID-19 (the global pandemic) is driving the growth of the patient-centric healthcare app market. Telehealth has the potential to address many of the key challenges in providing health services during the outbreak of COVID-19. Moreover, the pandemic has made video telemedicine the safest interactive system between patients and clinicians. For example, in May 2021, Proximus innovated in the field of e-Health with patient-centric teleconsultation app Doktr. The company announced the launch of Doktr, an innovative video teleconsultation service allowing patients with a basic primary care need to get in touch with a qualified doctor in a convenient and secure way. A patient-centric approach is a way the healthcare systems can establish a partnership among practitioners, patients, and their families to align decisions with patients' wants, needs, and preferences. Patient centric health care app helps provide information and deliver services to patients regarding their health, thereby improving patient's health. It offers access to health information and easy connectivity between patients and doctors. Moreover, these apps help users to stay updated about medication times, number of calories consumed, dehydration level in body, etc. Therefore, there is an increasing demand for patient-centric healthcare around the world, driving the growth of the patient centric healthcare app market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/08/the-outbreak-of-covid-19-to-augment.html

Surge in prevalence of genitourinary disorders is expected to boost the industry during the forecast period.Increase in number of pipeline drugs for genitourinary disorder is also expected to propel the market growth in coming years.Furthermore, surge in number of generics launched by big pharmaceutical companies as well as small and medium-sized drug manufacturers are anticipated to help the industry gain higher revenue in the next few years.

The major factor affecting the market include increase in research and development activities to introduce treatment and diagnostic methods to gain higher revenue during the forecast period. This allows the companies to create cost-effective methods and treatment options.Surge in the number of product launches, which meetthe demand posed by the market is anticipated to boost the market in the coming years.Increase in the prevalence of epidermal nevus syndrome associated cases would help the market propel in the next few years. However, lesser medical trained staffs may hamper the growth of the market.

Tech innovation in the healthcare industry is seeing some exciting developments that are changing lives and the latest of these is an ATM pharmacy.

Tech innovation in the healthcare industry is seeing some exciting developments that are changing lives and the latest of these is an ATM pharmacy.

CMS (Centers for Medicare and Medicaid Services) launched an alternative payment model - Primary Car. In this program, eligible clinicians can submit quality measures including for Advance Care Plan at the end of the performance year.

An antacid is simply a substance that neutralizes stomach acids and is typically used to alleviate heartburn, gastric indigestion, or an upset stomach with food. Some antacids are being used in the treatment of diarrhea and constipation. More recently marketed antacids now contain sodium salts of aluminum, magnesium, calcium, or other substances. Antacids are available both over the counter and by prescription. Antacids neutralize stomach acid as they neutralize the alkaline substance in your stomach - the very substance that causes most of the discomfort! In order to be sure that antacids work, it is important to consult your doctor or pharmacist Growing geriatric population suffering GERD, i.e. gastroesophageal reflux disease is expected to drive growth of the global antacid medications market. According to the National Center for Biotechnology Information (NCBI), around 20% of adults in western culture are affected with GERD. According to the same source, the prevalence of GERD in the U.S. was between 18.1% and 27.8% in 2020. GERD is one of the most common gastrointestinal disorders among the geriatric population. According to the World Health Organization (WHO), by 2050, the global population aged 65 years and above is expected to reach around 2 billion increasing from 900 million in 2015. Read More @ https://coherentmarketinsights-blog.blogspot.com/2021/01/antacid-medications-market-is-expanding.html

High prevalence of gastric cancer is expected to propel growth of the gastric cancer therapeutics market. For instance, according to The American Cancer Society, the U.S. is estimated to record about 26,560 cases of stomach cancer and about 11,180 people will die from this type of cancer in 2021. Moreover, R&D in oral chemotherapy for the treatment of gastric cancer is also expected to aid in growth of the market. For instance, in January 2021, Ascelia Pharma AB announced the clinical development plan for Oncoral, with which the company has the opportunity to develop a novel oral chemotherapy for the treatment of gastric cancer. Risk factors for gastric cancer may include smoking and a diet of highly processed or salty foods. Thus, high number of smokers is expected to offer lucrative growth opportunities for players in the gastric cancer therapeutics market. For instance, according to the World Health Organization's, May 2020 Update, tobacco leads to over 8 million deaths each year worldwide and over 7 million of those deaths are the result of direct tobacco use while around 1.2 million are the result of non-smokers being exposed to second-hand smoke. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/high-prevalence-of-gastric-cancer-and.html

Deep brain stimulation is a non-invasive neurosurgical treatment involving the placement of an electronic device called a simulator that emits electronic pulses, into the brain. These pulses are delivered to the area where there is the greatest need for stimulation, in the area known as the cerebral cortex. The purpose of this treatment is to increase brain function and improve brain function. This treatment is often used in conjunction with other procedures and is also very successful when it is used alone. Increasing prevalence of Parkinson's disease is expected to propel growth of the global deep brain stimulation devices market. For instance, according to the study, 'Prevalence of Parkinson's disease (PD) across North America", published in July 2018 in the journal Nature, the number of people suffering from PD is expected to reach 930,000 in 2020 and 1,238,000 in 2030. Increasing number of clinical trials for deep brain stimulation devices is expected to offer lucrative growth opportunities for players in the global deep brain stimulation devices market. For instance, in January 2021, Medtronic plc announced the first enrollment in ADAPT-PD, a trial evaluating the safety and efficacy of adaptive deep brain stimulation in patients with Parkinson's disease. Similarly, in October 2020, Keck Medicine of USC announced to enroll individuals in an international phase 3 clinical trial to examine the safety and effectiveness of deep brain stimulation to treat Alzheimer's. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/increasing-prevalence-of-parkinsons.html

Primary biliary cholangitis, also known as primary biliary cirrhosis, is an autoimmune disease of the liver. The auto-immune disorder can have a number of symptoms such as abdominal pain, fever, nausea, vomiting, abdominal bloating, diarrhea, liver tenderness or enlargement, jaundice, and ascites. In most of these symptoms, the patient may be experiencing inflammation at an early stage of the illness, although in some cases, symptoms do not appear until the disease has advanced to a more serious state. A definitive diagnosis can only be made by performing blood tests and ultrasound studies in order to determine the progression of the illness and its effects on the body. At an early stage, most patients who experience mild to moderate symptoms of primary biliary cholangitis exhibit no symptoms, whereas in some cases, symptoms manifest very quickly and rapidly worsen. In both conditions, the majority of affected individuals undergo treatment that is aimed at relieving pain and treating any complications that might occur. High prevalence of primary biliary cholangitis is expected to propel growth of the primary biliary cirrhosis drugs market. For instance, according to the study, 'Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis', published in Hepatology International in September 2019, the overall prevalence of primary biliary cholangitis was 118.75 cases per million in the Asia Pacific region, with the high, medium and low prevalence being in Japan and China (191.18 cases per million), New Zealand (99.16 cases per million) and South Korea and Australia (39.09 cases per million), respectively. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/high-prevalence-of-primary-biliary.html

Reportedly, physicians are struggling with ethical concerns amidst the coronavirus pandemic. Johns Hopkins Hospital and Berman Institute of Bioethics in Baltimore has launched a moral round program where physicians find a solution to their problems by interacting with other colleagues and learn to deal with the COVID situation.

Radiofrequency ablation is a relatively new method of reducing pain associated with back pain. In a recent review published by an organization that studies medical innovations, the Global Commission on Systemic Palliative Care (GCSPC) stated that the most common application for radiofrequency ablation is the treatment of pain in the spine, which has been used since the 1970s. There are many other applications, although these are two examples of the typical type of pain that this device is used to relieve. Rising prevalence of cancer is expected to drive growth of the global radiofrequency ablation device market during the forecast period. The number of cancer cases has increased over the years globally. According to the World Health Organization (WHO), in 2018, around 18.1 million new cases of cancer and 9.6 million deaths due to cancer were reported globally. According to the same source, around 70% of deaths from cancer occur in emerging economies with lung cancer accounting for the majority of deaths followed by breast cancer. Furthermore, according to the National Cancer Institute, in 2020, around 1,806,590 new cases of cancer are expected to be diagnosed in the U.S. with over 600,000 people dying from this disease. Such high incidence of cancer has led to increased demand for radiofrequency ablation devices. Hence, these factors are expected to drive growth global radiofrequency ablation device market during the forecast period. Furthermore, rising prevalence of cardiovascular disease combined with increasing number of ablation procedures is expected to boost the global radiofrequency ablation device market growth over the forecast period. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/radiofrequency-ablation-device-market.html

Endoscopy is a procedure that has been developed to assist in the removal of endometriosis from the human body. Endoscopy is also being used to help in the treatment of gallstones, cholecystitis, and gastric reflux disease among a number of other conditions. The recent developments in this industry have been driven by changes in government regulation and legislation. The increase in the number of malignancies and the introduction of fiscal policy in the region has resulted in political will on the part of the governments to strengthen public health services. Rising product approval for endoscopy devices by regulatory authorities is expected to drive growth of the global endoscopic stricture management device market during the forecast period. For instance, in January 2020, Pentax Medical received the U.S. Food and Drug Administration (FDA) approval for its Imagina Endoscopy System, which will be used in performing gastrointestinal procedures, digital image enhancement system with Pentax i-Scan. This endoscopy machine is equipped with an LED touch-screen interface, which removes the need for periodic bulb replacement. Besides, it is far more cost-efficient than the GI endoscopy system such as video endoscopy. Thus. These factors are expected to drive growth of the global endoscopic stricture management device market during the forecast period. Furthermore, increasing incidence of bleeding during surgical procedures combined with growing number of endoscopic procedures is expected to boost the global endoscopic stricture management device market growth over the forecast period. However, the lack of skilled healthcare professionals to perform surgical procedures, especially in emerging economies combined with complications related to endoscopic procedures such as bleeding and infection is expected to hamper the global endoscopic stricture management device market growth over the forecast period. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/end